Pages that link to "Q36447725"
Jump to navigation
Jump to search
The following pages link to Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa (Q36447725):
Displaying 50 items.
- Plant-based solutions for veterinary immunotherapeutics and prophylactics (Q27000876) (← links)
- Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteins (Q27311087) (← links)
- Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine (Q28728786) (← links)
- Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit (Q34424968) (← links)
- Innate endogenous adjuvants prime to desirable immune responses via mucosal routes (Q35143128) (← links)
- Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G. (Q35155937) (← links)
- Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy (Q36116250) (← links)
- Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity (Q36517179) (← links)
- Should a new tuberculosis vaccine be administered intranasally? (Q36744991) (← links)
- Vaccine adjuvants revisited (Q36750711) (← links)
- Mucosal vaccine adjuvants update (Q36758075) (← links)
- Dietary supplementation of mannan-oligosaccharide enhances neonatal immune responses in chickens during natural exposure to Eimeria spp (Q37154858) (← links)
- Nanoparticles for transcutaneous vaccination (Q37274692) (← links)
- Is intranasal vaccination a feasible solution for tuberculosis? (Q37316013) (← links)
- Adjuvants for porcine reproductive and respiratory syndrome virus vaccines (Q37373730) (← links)
- Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans (Q37423256) (← links)
- Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model (Q37453377) (← links)
- Chitosan-based systems for the delivery of vaccine antigens (Q37524050) (← links)
- Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity (Q37552013) (← links)
- Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity (Q37590335) (← links)
- Mucosal vaccines: recent progress in understanding the natural barriers. (Q37642613) (← links)
- Immune adjuvants in early life: targeting the innate immune system to overcome impaired adaptive response (Q37773306) (← links)
- Topical immunization strategies (Q37791415) (← links)
- Topical and mucosal liposomes for vaccine delivery. (Q37848296) (← links)
- Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization. (Q37849223) (← links)
- Opportunities for mitigating pathogen contamination during on-farm food production (Q37862840) (← links)
- Cholera-like enterotoxins and Regulatory T cells (Q37954306) (← links)
- Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties (Q38058640) (← links)
- Optimizing efficacy of mucosal vaccines. (Q38059754) (← links)
- Recent progress towards development of a Shigella vaccine (Q38068954) (← links)
- Adjuvants and delivery systems for antifungal vaccines: current state and future developments (Q38264288) (← links)
- Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization (Q38330161) (← links)
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies (Q38461061) (← links)
- Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit (Q38606892) (← links)
- New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy (Q38883770) (← links)
- Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras (Q41434206) (← links)
- Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs (Q41879113) (← links)
- Maltose-binding protein is a potential carrier for oral immunizations. (Q43918938) (← links)
- Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant (Q44205583) (← links)
- Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. (Q44289404) (← links)
- Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model (Q46125947) (← links)
- Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B. (Q46816112) (← links)
- Attachment of the outer membrane lipoprotein (OprI) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens (Q48008222) (← links)
- Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties (Q48923937) (← links)
- Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs (Q49065309) (← links)
- Immunization of sheep with a combination of intiminγ, EspA and EspB decreases Escherichia coli O157:H7 shedding. (Q49078870) (← links)
- GITR contributes to the systemic adjuvanticity of the Escherichia coli heat-labile enterotoxin. (Q54393653) (← links)
- Intranasal inoculate of influenza virus vaccine against lethal virus challenge (Q59359566) (← links)
- WITHDRAWN: An investigation on the protective efficiency of recombinant ovalbumin and its mutants against anaphylaxis in mice (Q83061540) (← links)
- Primary porcine CD11R1+ antigen-presenting cells isolated from small intestinal mucosa mature but lose their T cell stimulatory function in response to cholera toxin treatment (Q84931753) (← links)